Inventor
PRIEBE WALDEMAR
US42 patents
⚠️ This page may combine multiple inventors who share the name “PRIEBE WALDEMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
19 patentsUS4863739ASep 5, 1989
Liposome compositions of anthracycline derivatives
UNIV TEXAS24 citations92
US7238366B1Jul 3, 2007
Submicron liposome suspensions obtained from preliposome lyophilizates
UNIV TEXAS24 citations91
US5902604AMay 11, 1999
Submicron liposome suspensions obtained from preliposome lyophilizates
UNIV TEXAS29 citations91
US7745468B2Jun 29, 2010
Compounds for treatment of cell proliferative diseases
UNIV TEXAS12 citations90
US5132290AJul 21, 1992
Esters of 3'-deaminodoxorubicin and liposomal compositions thereof
UNIV TEXAS11 citations74
US6437105B1Aug 20, 2002
Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
UNIV TEXAS11 citations72
US11026960B2Jun 8, 2021
Esters of 2-deoxy-monosaccharides with anti proliferative activity
UNIV TEXAS1 citations71
US10201554B2Feb 12, 2019
Esters of 2-deoxy-monosacharides with anti proliferative activity
UNIV TEXAS2 citations71
US12257262B2Mar 25, 2025
Method of reconstituting liposomal annamycin
UNIV TEXAS1 citations61
US12257261B2Mar 25, 2025
Preparation of preliposomal Annamycin lyophilizate
UNIV TEXAS1 citations61
US11925654B2Mar 12, 2024
Esters of 2-deoxy-monosaccharides with anti proliferative activity
UNIV TEXAS0 citations61
US9000179B2Apr 7, 2015
Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
UNIV TEXAS1 citations61
US9096499B2Aug 4, 2015
Compounds for treatment of cell proliferative diseases
UNIV TEXAS1 citations60
US7365096B2Apr 29, 2008
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
UNIV TEXAS3 citations58
US5977327ANov 2, 1999
Synthesis of annamycin
UNIV TEXAS6 citations58
US10703721B2Jul 7, 2020
Caffeic acid derivatives and uses thereof
UNIV TEXAS1 citations53
US6680300B2Jan 20, 2004
Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
UNIV TEXAS1 citations51
US7928062B2Apr 19, 2011
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
UNIV TEXAS0 citations48
US10358439B2Jul 23, 2019
DNA binding agents with a minor groove binding tail
UNIV TEXAS0 citations40
PRIEBE WALDEMAR
9 patentsUS8143412B2Mar 27, 2012
Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
PRIEBE WALDEMAR27 citations91
US5625043AApr 29, 1997
Anthracyclines with unusually high activity against cells resistant to doxorubicin and its analogs
PRIEBE WALDEMAR21 citations91
US8299033B2Oct 30, 2012
Iodo-hexose compounds useful to treat cancer
PRIEBE WALDEMAR14 citations82
US8927506B2Jan 6, 2015
Acetates of 2-deoxy monosaccharides with anticancer activity
PRIEBE WALDEMAR5 citations71
US8450337B2May 28, 2013
Methods of treating skin disorders with caffeic acid analogs
PRIEBE WALDEMAR3 citations61
US8779151B2Jul 15, 2014
Orally bioavailable caffeic acid related anticancer drugs
PRIEBE WALDEMAR2 citations60
US8648102B2Feb 11, 2014
Compounds for treatment of cell proliferative diseases
PRIEBE WALDEMAR1 citations60
US8119827B2Feb 21, 2012
Compounds for treatment of cell proliferative diseases
PRIEBE WALDEMAR1 citations60
US8637675B2Jan 28, 2014
Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)
PRIEBE WALDEMAR1 citations51
HOUSTON PHARMACEUTICALS INC
3 patentsUS6673907B2Jan 6, 2004
Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics
HOUSTON PHARMACEUTICALS INC17 citations89
US7109177B2Sep 19, 2006
Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics
HOUSTON PHARMACEUTICALS INC3 citations59
US7557090B2Jul 7, 2009
Anthracycline antibiotics and methods of treating cancer using the same
HOUSTON PHARMACEUTICALS INC3 citations57
(unassigned)
2 patentsUS5874412AFeb 23, 1999
Bis-anthracyclines with high activity against doxorubicin resistant tumors
97 citations95
US6355784B1Mar 12, 2002
Methods and compositions for the manufacture of halogenated anthracyclines with increased antitumor activity, other anthracyclines, halogenated sugars, and glycosyl donors
3 citations59